National Institute of Allergy and Infectious Diseases Investor
National Institute of Allergy and Infectious Diseases (NIAID) conducts fundamental and applied research to gain a comprehensive understanding of infectious, immunological, and allergic diseases, as well as to develop new techniques for their treatment, prevention, and eventual eradication. Over six decades, NIAID research has resulted in the development of novel treatments, vaccines, and diagnostic methods, as well as other breakthroughs that have significantly improved the quality of life for millions of people worldwide, including in the United States.
Industry:
Clinical AI
Technology:
Clinical Decision Support Systems (CDSS)
Number Of Exists:
4
Investor Type:
Donors
Headquarters:
Bethesda,Maryland,United States,North America
Funding Status:
private
Employee Number:
1.5K
Founded Date:
1887-01-01